FDA 483 Observations in the Laboratory. What went wrong? How can they be avoided? - Webinar By GlobalCompliancePanel

12 January 2011, Wilmington, United States


Introduction
In order to proactively address areas of concern to the FDA and other regulators, All units within each pharmaceutical firm should review recent regulatory observations and proactively establish programs or systems to address the regulatory concerns.
Venue
Online Training Webinar

Online Training Webinar, 1000 N West Street | Suite 1200, Wilmington, 19801, United States

Organised by
GlobalCompliancePanel
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*